Ghrelin capacity for food but also dramatically lowers ghrelin levels compared to both lean controls and those that lost weight through dieting alone. However, studies are conflicting as to whether or not ghrelin levels return to nearly normal with gastric bypass patients in the long term after weight loss has stabilized. Bariatric surgeries involving vertical-sleeve gastrectomy reduce plasma ghrelin levels by about 60% in the long term. Ghrelin plasma concentration increases with age and this may contribute to the tendency for weight gain as people age. Ghrelin Ghrelin (pronounced ), the "hunger hormone", also known as lenomorelin (INN), is a peptide
Ghrelin promotilin and both are members of the motilin family. Unlike the case of many other endogenous peptides, ghrelin is able to cross the blood-brain-barrier, giving exogenously-administered ghrelin unique clinical potential. Ghrelin was discovered after the ghrelin receptor (called growth hormone secretagogue type 1A receptor or GHS-R) was discovered in 1996 and was reported in 1999. The hormone name is based on its role as a "growth hormone-releasing peptide", with reference to the Proto-Indo-European root "gʰre-", meaning "to grow". The "GHRL" gene produces mRNA which has four exons. Five products arise: the first is the 117-amino acid "preproghrelin". (It is homologous